Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Translocator Protein 18 kDa (TSPO) Expression in Multiple Sclerosis Patients.
Purkinje cell fusion and binucleate heterokaryon formation in multiple sclerosis cerebellum.
CSF abnormalities can be predicted by VEP and MRI pathology in the examination of optic neuritis.
Current and emerging therapies in multiple sclerosis: a systematic review.
Patient-related factors may affect the outcome of neuropsychological rehabilitation in multiple sclerosis.
Automatic multiple sclerosis lesion detection in brain MRI by FLAIR thresholding.
Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis
Neuromyelitis optica in pregnancy complicated by posterior reversible encephalopathy syndrome, eclampsia and fetal death.
Effects of vitamin D on retinal nerve fiber layer in vitamin D deficient patients with optic neuritis: Preliminary findings of a randomized, placebo-controlled trial.
Multi-parametric structural magnetic resonance imaging in relation to cognitive dysfunction in long-standing multiple sclerosis.
MR imaging and cognitive correlates of relapsing-remitting multiple sclerosis patients with cerebellar symptoms.
Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex(R)) in people with multiple sclerosis: a new approach.
Assessing spinal cord function in multiple sclerosis with functional neuroimaging: insights and limitations.
Cognitive impairment is correlated with reduced quality of life in patients with clinically isolated syndrome.
Sphingosine 1-phosphate receptor agonists: a patent review (2010 - 2012).
Sphingolipids in neuroinflammation.
On the contribution of Thomas Clifford Allbutt, F.R.S., to the early history of neuromyelitis optica.
What is needed to keep persons with multiple sclerosis vitamin D-sufficient throughout the year?
A Group Kickboxing Program for Improving Balance, Mobility, and Quality of Life in Individuals With Multiple Sclerosis: A Pilot Study.
Beneficial effects of Rituximab in patients with anti-MAG (myelin-associated glycoprotein) neuropathy: case reports.
Epithelial v-like antigen mediates efficacy of anti-alpha4 integrin treatment in a mouse model of multiple sclerosis.
FDA Drug Safety Communication: FDA investigating rare brain infection in patient taking Gilenya (fingolimod)
Extensive acute disseminated encephalomyelitis in a young girl responding to intravenous methylprednisolone.
Notch Signaling and T-Helper Cells in EAE/MS.
Choosing the best treatment for multiple sclerosis: comparative effectiveness, safety, and other factors involved in disease-modifying therapy choice.

Pages